Facilitated subcutaneous immunoglobulin (fSCIg) therapy – practical considerations

There is an increasing range of therapeutic options for primary antibody-deficient patients who require replacement immunoglobulin. These include intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), rapid push SCIg and most recently recombinant human hyaluronidase-facilitated SCIg...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Exp Immunol
Autori principali: Ponsford, M, Carne, E, Kingdon, C, Joyce, C, Price, C, Williams, C, El-Shanawany, T, Williams, P, Jolles, S
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2015
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636892/
https://ncbi.nlm.nih.gov/pubmed/26288095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12694
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi